ClinicalTrials.Veeva

Menu

Study on the Effect of Transcranial Magnetic Stimulation on the Perception of Emotional Images (SAME-M)

P

Prof. Dominique de Quervain, MD

Status

Enrolling

Conditions

Emotional Memory

Treatments

Device: Control continuous 30 Hz thetaburst transcranial magnetic stimulation
Device: Experimental continuous 30 Hz thetaburst transcranial magnetic stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT07191275
2025-01622

Details and patient eligibility

About

The goal of the current clinical trial is to investigate whether transcranial magnetic stimulation (TMS) over specific brain areas can influence the perception of emotional images and emotional memory. TMS is a non-invasive superficial brain stimulation generated by a magnetic field. The results of the study aim to provide valuable insights for the use of TMS in the investigation of mental processes.

Enrollment

33 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Generally healthy
  • Normotensive (BP 90/60mmHg - 140/90mmHg)
  • BMI: 18 - 30 kg/m2
  • Fluent in speaking German

Exclusion criteria

  • Metal in the head area (e.g., splinters, fragments, clips, etc.)
  • Implanted neurostimulator (e.g., DBS, epidural/subdural, VNS)
  • Cardiac pacemaker or intracardiac lines
  • Medication infusion device
  • Non removable metal piercings in the head area, pivot teeth (retainers are no exclusion criterion)
  • Tattoos (head area) less than 3 months old or older than 20 years
  • Condition after neurosurgery
  • Hearing problems or tinnitus
  • Not able to sit still due to tremor, tics, itching
  • History of repeated syncope
  • Head trauma diagnosed as concussion or associated with loss of consciousness
  • diagnosis of epilepsy, or a convulsion or a seizure in the past of the participant or his/her close family (parents and siblings)
  • TMS in the past showing problems
  • Spinal or ventricular derivations
  • Positive pregnancy test
  • Alcohol intake 12 hours before TMS visits
  • Regular intake of any medication (excluding oral contraceptives)
  • CNS-active medication or illegal drugs 48h before TMS visits
  • Individual's rMT above the limits of rTMS device
  • Suicidal tendency as measured by Montgomery-Åsberg Depression Rating Scale (MADRS), item 10 > 0

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

33 participants in 2 patient groups

Participants starting with experimental condition
Experimental group
Description:
Bilateral continuous theta burst stimulation (cTBS) 30 Hz to the temporo-occipital cortex
Treatment:
Device: Experimental continuous 30 Hz thetaburst transcranial magnetic stimulation
Device: Control continuous 30 Hz thetaburst transcranial magnetic stimulation
Participants starting with control condition
Active Comparator group
Description:
Active control condition using bilateral continuous theta burst stimulation (cTBS) 30 Hz to the superior parietal cortex
Treatment:
Device: Experimental continuous 30 Hz thetaburst transcranial magnetic stimulation
Device: Control continuous 30 Hz thetaburst transcranial magnetic stimulation

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Ehssan Amini, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems